Your friend glances at the bottle on your desk and asks what nootropic even means, and you realize you cannot answer without hedging. The label promises sharper focus, but the word has been stretched so far that it may not promise anything precise at all. You want to know whether the term still has a definition worth trusting, or whether it has become pure marketing.
You are standing in the supplements aisle, holding a bottle whose label promises sharper focus, and you cannot tell whether the word on it means anything at all. The term nootropics has drifted so far from its original sense that a shopper can be forgiven for assuming it is just marketing. The useful answer is that nootropics began as a precise scientific category with five strict criteria, and almost nothing sold under that name today meets all of them. Knowing the original definition lets you read a label and see what is actually being claimed. Good evidence on most over-the-counter nootropics is limited, and the honest position is that we would need long-term trials in healthy adults, with agreed measures of cognition, before saying a supplement reliably improves memory or attention.
The five original criteria
The word nootropic was coined by the Romanian pharmacist and psychologist Corneliu Giurgea, who set out five conditions a substance had to satisfy before he would call it a nootropic. The criteria are remembered as a definition box, and they are stricter than most people expect.
Giurgea’s five criteria
- Enhance learning and memory
- Help the brain resist disruption
- Protect the brain from injury
- Improve cortical and subcortical control
- Be essentially non-toxic
A true nootropic should enhance learning and memory. It should help the brain resist disruption from injury, low oxygen, or other insults. It should protect the brain from chemical or physical injury. It should improve the efficiency of cortical and subcortical control mechanisms. And it should be essentially non-toxic, with few or no side effects.
That last criterion is the one that quietly eliminates most candidates. A substance can sharpen attention and still fail as a nootropic if it raises blood pressure, disturbs sleep, or carries a meaningful risk of dependence. Giurgea was describing a class of compounds that would improve cognition without the costs of a stimulant.
Your nootropic may not fit the testWhy almost nothing labelled nootropic todayWatch the video to see the five original criteria that most pills labelled nootropic quietly fail.
Prescription drugs that are called nootropics
Some prescription medicines are discussed as nootropics because they can improve alertness or focus in people with diagnosed conditions. Stimulants used for attention deficit hyperactivity disorder and wakefulness-promoting agents used for narcolepsy are the clearest examples. They require a prescriber, and they are not lifestyle supplements.
These drugs do not meet all five criteria. They can raise heart rate and blood pressure, carry a risk of misuse, and are not essentially non-toxic in the way Giurgea intended. Their benefits are real for the conditions they treat, but calling them nootropics stretches the term until it loses its meaning.
Racetams are another group often mentioned in nootropic discussions. They are not approved as drugs in the United States, and their legal status varies elsewhere. The evidence for their cognitive effects in healthy people is thin, and the gap between online enthusiasm and published research is wide.
Caffeine and the stimulant exception
Caffeine is the most common substance people use to feel more alert, and it is sometimes grouped with nootropics in casual conversation. It improves attention and reduces fatigue, but it does not satisfy the original definition. It raises heart rate, can disturb sleep, and produces tolerance and withdrawal.
Feeling alert vs nootropic
- Myth: Feeling awake means your memory is improving.
- Fact: Alertness and memory are not the same.
- Myth: Caffeine is a nootropic.
- Fact: Caffeine raises heart rate and disturbs sleep.
The distinction matters because it exposes a trade-off. A stimulant can make you feel sharper for a few hours while leaving your memory unchanged or even impaired by poor sleep the next day. A nootropic in the strict sense would have to improve cognition without that rebound.
The mistake people make is to treat the feeling of alertness as evidence of cognitive enhancement. Feeling awake is not the same as remembering more, and a substance can produce the first without delivering the second.
Herbal and nutrient compounds
Ginkgo biloba is one of the most studied herbal supplements promoted for brain health. The evidence is not encouraging. Large trials in older adults with normal cognition or mild cognitive impairment found that ginkgo extract did not reduce the risk of developing dementia. One of these, the Ginkgo Evaluation of Memory study, followed more than 3,000 people aged 75 or older for a median of six years and found no difference between ginkgo and placebo in rates of dementia or Alzheimer’s disease.
Common candidates vs criteria
| Substance | Meets all five criteria |
|---|---|
| Stimulants | No |
| Racetams | No |
| Caffeine | No |
| Ginkgo biloba | No |
| Omega-3s | No |
Ginkgo has not been shown to be effective for any of the conditions for which it has been studied. Some research suggests a modest benefit for dementia symptoms at relatively high doses, but the evidence is inconsistent. For healthy people, it is uncertain whether ginkgo influences cognitive performance at all, and much of the research is of low quality.
Omega-3 fatty acids are another common candidate. A 2022 review of 33 studies suggested that dietary and supplemental omega-3s may have a protective effect against cognitive decline for healthy people without preexisting dementia, but there was no effect on cognition for people already diagnosed with Alzheimer’s disease. A 2018 review of seven studies in people aged 55 to 90 with mild to moderate Alzheimer’s found that supplementation may be beneficial at disease onset, when impairment is slight, but the authors said there is not enough evidence to support treatment of the disease.
Neither ginkgo nor omega-3s meets the five criteria. They are not essentially non-toxic in the strict sense, since ginkgo can increase bleeding risk in people taking anticoagulants, and omega-3 supplements have mild side effects including unpleasant taste, bad breath, and gastrointestinal symptoms. More importantly, the evidence that they enhance cognition in healthy adults is weak or absent.
Why the label has drifted
The gap between the strict definition and what is sold comes down to regulation. Dietary supplements are not approved by the U.S. Food and Drug Administration before they are sold. Manufacturers are responsible for evaluating safety and labeling, and the rules are less strict than those for drugs.
The word nootropic becomes a suggestion rather than a classification. A buyer who knows the five criteria can see that most of what is labeled nootropic today is either a stimulant, an unapproved drug, or a supplement with limited evidence.
The decision that depends on context is whether you want a substance that makes you feel more alert now, or one that might support cognition over years. The first is easy to find and easy to feel. The second is hard to find and harder to prove.
When the same blank keeps coming back, watch the full video and sit with the wider question it raises.
If this has happened more than once, the single slip is the small version of it, and watch the full video to hear how that wider pattern is framed.
In this section
Everything on Supplements & food →
▶ Watch the memory video
